Case report of aseptic meningitis in a patient with Crohn's disease under infliximab therapy

Inflammatory Bowel Diseases

Volumn 17, Issue 2, 2011, Pages

  Manthey, Carolin ^a   Lohse, Ansgar W ^a   Pace, Andrea ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; IMMUNOGLOBULIN G; INFLIXIMAB; OLIGOCLONAL BAND;

ADULT; ANAMNESIS; ASEPTIC MENINGITIS; CASE REPORT; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CROHN DISEASE; FEMALE; HEADACHE; HUMAN; INTRAOCULAR PRESSURE; LETTER; LEUKOCYTOSIS; LUMBAR PUNCTURE; LYMPHOCYTE; PRIORITY JOURNAL;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; HUMANS; MENINGITIS, ASEPTIC;

EID: 78651291679     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21324     Document Type: Letter

References (7)

1. Velayos FS, Sandborn WJ,. Positioning biologic therapy for Crohn's disease and ulcerative colitis. Curr Gastroenterol Rep. 2007; 9: 521-527.
2. Rutgeerts P, Van Assche G, Vermeire S,. Review article: infliximab therapy for inflammatory bowel disease-seven years on. Aliment Pharmacol Ther. 2006; 23: 451-463.
3. Periodic Safety Update Report (PSUR). Infliximab. EMEA 2005, published online: April 14 2005.
4. Marotte H, Charrin JE, Miossec P,. Infliximab-induced aseptic meningitis. Lancet. 2001; 358: 1784.
5. Hegde N, Gayomali C, Rich MW,. Infliximab-induced headache and infliximab-induced meningitis: two ends of the same spectrum? South Med J. 2005; 98: 564-566.
6. Tissot B, Visée S, Pilette C, et al. Lymphocytic meningitis with infliximab for ulcerative colitis. Gastroenterol Clin Biol. 2006; 30: 1420-1422.
7. Gamarra RM, McGraw SD, Drelichman VS, et al. Serum sickness-like reactions in patients receiving intravenous infliximab. J Emerg Med. 2006; 30: 41-44.